EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Obesity and Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Impact, and Management Strategies

Pallavi Shirsat, Malavika Balachandran, Venkata Sushma Chamarthi, Kunal Sonavane

Journal of CardioRenal Medicine · 08.10.2025 · 1 (1) · 4

DOI: 10.3390/jcrm1010004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of CardioRenal Medicine, online erschienen am 08.10.2025. Verfasst von Pallavi Shirsat und 3 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a significant public health crisis with increasing rates worldwide. Chronic kidney disease (CKD) has also emerged as a leading cause of death worldwide. This review explores the intricate connection between obesity and CKD, discussing the underlying biological mechanisms, clinical consequences of their coexistence, and strategies for evidence-based management. We conducted an extensive literature review of peer-reviewed studies examining obesity–CKD relationships, including epidemiological studies, mechanistic research, clinical trials, and meta-analyses from major medical databases. Obesity serves as both a risk factor for de novo CKD development and a paradoxical protective factor observed in some studies of advanced CKD, particularly in dialysis populations. This review synthesizes current evidence on obesity-related glomerulopathy, the impact of obesity on CKD progression to end-stage renal disease, and the phenomenon known as the “obesity paradox”. Management approaches, including lifestyle interventions, pharmacological treatments, and bariatric surgery, show varying efficacy across different CKD stages. The multifaceted relationship between obesity and CKD necessitates individualized, multidisciplinary approaches to optimize patient outcomes while addressing the unique challenges presented by this complex comorbidity. Early intervention in obese patients may prevent CKD development, while careful management is required in advanced CKD stages where the obesity paradox may confer survival benefits.

Zitieren

APA

Shirsat, P., Balachandran, M., Chamarthi, V. S., & Sonavane, K. (2025). Obesity and Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Impact, and Management Strategies. Journal of CardioRenal Medicine, 1(1), 4. https://doi.org/10.3390/jcrm1010004

Vancouver

Shirsat P, Balachandran M, Chamarthi VS, Sonavane K. Obesity and Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Impact, and Management Strategies. Journal of CardioRenal Medicine. 2025;1(1):4. doi:10.3390/jcrm1010004

BibTeX
@article{Shirsat2025,
  author = {Shirsat, Pallavi and Balachandran, Malavika and Chamarthi, Venkata Sushma and Sonavane, Kunal},
  title = {Obesity and Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Impact, and Management Strategies},
  journal = {Journal of CardioRenal Medicine},
  year = {2025},
  volume = {1},
  number = {1},
  pages = {4},
  doi = {10.3390/jcrm1010004}
}
Kostenlos starten →